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The nicotinic acetylcholine receptor (nAChR) is a ligand-gated 
ion channel protein that mediates fast excitatory synaptic transmis-
sion in the peripheral and central nervous systems. Changes in the 
structure and function of the AChR can lead to serious impairment 
of physiological processes. In this study, we combined site-directed 
mutagenesis,  radioligand  binding  assays,  electrophysiological 
recordings and Fourier analyses to characterize the functional role 
and structural aspects of the bM4 transmembrane domain of the 
Torpedo AChR. We performed tryptophan replacements, from resi-
dues L438 through F455, along the bM4 transmembrane domain. 
Expression levels of mutants F439W-G450W and F452W-I454W 
produced peak currents similar to or lower than those in wild-type 
(WT). Tryptophan substitutions at positions L438 and T451 led 
to a deficiency in either subunit expression or receptor assembly. 
Mutations L440W, V442W, C447W and S453W produced a gain-
of-function  response.  Mutation  F455W  produced  a  loss  of  ion 
channel function. The periodicity profile of the normalized expres-
sion level (closed state) and EC50 (open state) revealed a minor 
conformational change of 0.4 residues/turn of the bM4 domain. 
These findings suggest that a minor movement of the bM4 domain 
occurs during channel activation.
Introduction
The  nicotinic  acetylcholine  receptor  (nAChR)  is  an  integral 
membrane protein that belongs to the superfamily of ligand-gated 
ion channels.1-4 The nAChR from Torpedo californica is an allosteric 
and integral membrane protein comprised of five protein subunits 
arranged  pseudo-symmetrically  in  a  stoichiometry  of  α2bγδ.2,5,6 
Each subunit contains a large hydrophilic N-terminus, four trans-
membrane domains (TD) of 20–30 amino acids regions named M1, 
M2, M3 and M4, a variable intracellular loop between M3 and M4, 
and a short extracellular C-terminus.7,8 The M2 domain, which sits 
closest to the pore lumen, forms the pore lining in the closed state 
conformation,  whereas  both  M1  and  M2  domains  contribute  to 
the formation of the ion channel pore in the open state conforma-
tion.9-11 The M3 and M4 domains are in contact with the lipid 
membrane12,13  away  from  the  ion  channel  pore  and  the  ligand 
binding site.14
A high resolution structure from a crystallized AChR remains to 
be elucidated; however, structural information has been reported by 
a model of the Torpedo marmorata nAChR at 4 Å resolution.14 This 
model  provided  detailed  information  on  the  secondary  structure 
and global arrangement of the TDs and is the best approximation 
to the AChR structure. Fourier transform infrared spectroscopy,15-17 
photoaffinity labeling,12,13 and two-dimensional 1H-NMR spectros-
copy18 are other techniques utilized to probe both AChR structure 
and function. Recently, using some of these techniques, the crystal 
structure of the extracellular domain of nAChR α1 subunit has been 
reported at 1.94 Å resolution. This article provided detailed informa-
tion about the cavity of the extracellular domain of nAChR α1 but 
no information about the TDs of the α1subunit.19
Some methods such as X-ray crystallography and NMR spec-
troscopy are not standard techniques used with all proteins. Many 
proteins do not form crystals, and many are too large to solve by 
NMR.20 Although tryptophan-scanning mutagenesis (TrpScanM) is 
not a high resolution method, it is a good procedure for determining 
the structure of intractable proteins. For example, TrpScanM has been 
used successfully to characterize transmembrane domains of proteins 
such  as  inward  rectifier  potassium  channels,21,22  voltage-activated 
potassium channels,23-28 nAChR channels,29-33 glutamate receptor 
channels,34  GABAA  receptor  channels,35  and  P2X4  receptors.36 
TrpScanM has been used to collect valuable data about the structure 
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and function of various transmembrane domains of the AChR. For 
example, the pioneer studies of mutagenesis in the lipid-exposed posi-
tion replacement of αCys418 and αCys421 by tryptophan resulted 
in a substantial increase in channel open time and demonstrated the 
important role of the lipid-exposed transmembrane domains to gating 
machinery of the AChR. Our group has extended the TrpScanM to 
αTM4,29 γTM4,32 γTM3,37 αTM3,30,33 and bTM3,31 to assess the 
structure and function of the AChR. These earlier studies identi-
fied residues at which a tryptophan replacement results in a robust 
gain in function, including, for example, αCys418,38 αVal425,29 
bCys447,39 γLeu296,37 and αThr422.40 Moreover, prior analyses of 
the changes in AChR function and expression as a function of the 
mutation position or periodicity provided valuable information used 
to predict the secondary structure of various TDs of the AChR. The 
periodicity for αTM3-TM4, γTM4 and bTM3 are consistent with 
a helical structure for these TDs. In the present study, we extended 
the tryptophan-scanning approach to monitor the conformational 
changes  of  the  Torpedo  AChR  bM4  domain.  The  TrpScanM 
approach reported allowed us to construct structural models of the 
Torpedo AChR bM4 domain in both the closed- and open-channel 
states.  The  interpretations  of  these  structural  models  suggest  an 
overall helical secondary structure for the bM4 domain. However, 
in contrast to others domains, the bM4 domain displays either very 
discrete or localized conformational changes.
Results
Functional characterization of the M4 transmembrane domain 
mutations:  expression  of  bM4  mutants.  Eighteen  residues,  from 
L438 to F455, within the M4 TD of the b subunit of T. californica 
AChR were individually replaced with tryptophan. Transcripts of 
mRNA were synthesized and injected into X. laevis oocytes, and the 
level of cell-surface expression of mutant AChRs was assessed by 
[125I]α-bungarotoxin ([125I]α-BgTx) binding analysis, as described 
in Experimental Procedures. All the bM4-mutants showed different 
nAChR  expression  levels  (Table  1). Twelve  of  the  bM4-mutants 
(L438W,  F439W,  Y441W,  V442W,  F444W,  V445W,  I446W, 
C447W, I449W, G450W, T451W and F455W) displayed a signifi-
cant reduction in nAChR expression levels as compared to wild-type 
(WT). According to previous photolabeling affinity studies, L438, 
F439, V442, V445, I449, G450, T451 and I454 are believed to 
be oriented toward the interior of the nAChR, so substitution of 
tryptophan at these given positions could cause a steric hindrance 
that could affect the stability of the TD and the expression levels of 
the AChR, consistent with the present results. Mutations at L438W, 
T451W and F455W were also incapable of eliciting acetylcholine 
(ACh)-induced currents (Table 1). The three non-functional mutants 
L438W (0.22 fmols), T451W (0.32 fmols) and F455W (1.16 fmols) 
gave expression levels lower than WT (9.2 fmols) and equivalent to 
other functional mutants in different AChR subunits. For example, 
in  previous TrpScanM,  the  mutant  bL284W31  gave  a  functional 
mutant that had an expression level of 0.30 fmols, similar to the 
mutant  T451W.  The  mutant  bV295W31  also  gave  a  functional 
receptor with an expression level of 0.4 fmols. It is noteworthy that 
other  mutations  with  similar  or  lower  expression  levels  (F444W 
(1.3 fmols) and I449W (0.57 fmols), respectively) in our scanning 
produced significant functional response. According to our data base 
of more than 300 lipid-exposed mutations, a decreased AChR expres-
sion does not necessarily mean that the receptor is not functional. For 
Table 1  Biophysical parameters of the wild-type and bM4-mutant AChR
AChR type  Expression level (fmol)  EC50 (µM)  Hill coefficient  Imax (-nA/fmol)  Imax (-nA)
2αbδγ (Wild type)  9.2 ± 1.7  22.7 ± 3.70  1.35 ± 0.059  1674 ± 230  7047 ± 718
2αb(L438W)δγ  0.22 ± 0.08#  N.D.  N.D.  N.D.  N.D.
2αb(F439W)δγ  2.2 ± 0.14#  7.6 ± 1.80*  1.20 ± 0.13  1480 ± 205  3100 ± 381*
2αb(L440W)δγ  6.2 ± 0.70*  12.2 ± 0.99*  1.37 ± 0.088  1832 ± 236  10850 ± 657+
2αb(Y441W)δγ  2.4 ± 0.96#  99.4 ± 38#  1.21 ± 0.17  814 ± 516+  2493 ± 2255
2αb(V442W)δγ  2.2 ± 0.20#  11.8 ± 0.56*  1.42 ± 0.065  3683 ± 620*  7810 ± 1219
2αb(F443W)δγ  5.5 ± 0.70*  5.2 ± 0.14#  1.31 ± 0.087  1316 ± 203  6843 ± 253
2αb(F444W)δγ  1.3 ± 0.40#  49.3 ± 5.30*  1.64 ± 0.11  3357 ± 605*  3515 ± 663+
2αb(V445W)δγ  2.6 ± 0.50#  18.6 ± 3.04+  1.55 ± 0.067  1373 ± 268*  3196 ± 313*
2αb(I446W)δγ  2.9 ± 0.64#  23.4 ± 3.40  1.31 ± 0.087  2366 ± 669*  6027 ± 688
2αb(C447W)δγ  3.5 ± 0.62*  5.8 ± 1.13#  1.11 ± 0.24  3283 ± 448*  13650 ± 432#
2αb(S448W)δγ  7.90 ± 1.52  21.2 ± 5.83  1.31 ± 0.12  568 ± 141*  3479 ± 370+
2αb(I449W)δγ  0.57 ± 0.09#  128.1 ± 20.33#  1.61 ± 0.072  5400 ± 2155*  2700 ± 600#
2αb(G450W)δγ  2.7 ± 0.26#  39.8 ± 3.83+  1.34 ± 0.059  804 ± 115*  2167 ± 355#
2αb(T451W)δγ  0.32 ± 0.14#  N.D.  N.D.  N.D.  N.D.
2αb(F452W)δγ  5.03 ± 1.03*  28.0 ± 4.12  1.38 ± 0.052  1211 ± 232  5471 ± 590
2αb(S453W)δγ  4.2 ± 0.40*  16.82 ± 1.5*  1.30 ± 0.088  2985 ± 350+  11179 ± 642+
2αb(I454W)δγ  6.8 ± 1.14  24.8 ± 4.03  1.52 ± 0.087  984 ± 139+  5857 ± 594
2αb(F455W)δγ  1.16 ± 0.25#  N.D.  N.D.  N.D.  N.D.
Values are given as the mean ± the standard error of the mean for each parameter and were calculated using 5–16 oocytes. The normalized response (nA/fmol) of each oocyte was assessed as the ratio of the macroscopic 
peak current (nA) generated at 300 µM ACh to the superficial [125I]-α-BgTx binding (fmol). #means p < 0.001, *means 0.001 ≤ p < 0.01 and +means 0.01 ≤ p < 0.05. ND, means no detectable current.Tryptophan-scanning of the acetylcholine receptor bM4 domain
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Structural  differences  between  closed  and  open  states.  The 
periodicity  of  nAChR  expression  (fmol/Å3)  revealed  structural 
information  of  the  bM4  TD  in  its  closed  state,19,29-33,37  given 
that the toxin binding assays were performed in the absence of the 
agonist (Experimental Procedures). Oocytes are incubated in 20 nM 
[125I]-α-BgTx, 5 mg/mL BSA, and MOR-2 without EGTA at room 
temperature for 2 hours. A typical expression level of AChR in the 
oocyte surface is 3–10 fmols; therefore, toxin excess is in the order 
of ~2 x 107 fold to assure that all AChRs in the oocyte surface are 
completely blocked by the toxin. After α-BgTx incubation, oocytes 
do not display ACh-induced currents at any concentration of the 
agonist; thus, this is a clear indication that under these conditions all 
AChRs on the oocyte surface are bound with [125I]-α-BgTx. Recent 
studies from the crystal structure of the extracellular domain of α1 
nAChR demonstrate that [125I]-α-BgTx binds to the extracellular 
domain of the nAChR via protein-sugar interactions.19 We would 
like to emphasize that under these conditions, AChRs expressed in 
the oocyte surface have never been exposed to agonist; therefore, we 
basically assure that all receptors are “locked” in the closed confor-
mation without a previous activation by agonist. In contrast, the 
periodicity profile estimated from EC50 values revealed structural 
information of the bM4 TD in an open-channel state, given that 
the EC50 value estimates the functional state of the nAChR. The 
periodicity profile of the closed state showed an ordered oscillation 
along  all  positions,  whereas  the  periodicity  profile  of  the  open-
channel state displayed an ordered oscillation along all positions but 
a small distortion at the middle of the bM4 TD between positions 
C447 and T451. The ordered oscillatory pattern observed along all 
closed- and open-state conformations is consistent with a helical 
motif (Fig. 2A and C).
The periodicity profiles of the bM4 TD in the closed and open 
states illustrated patterns of 2.43 ± 0.71 and 2.14 ± 0.39 amino 
acids per helical turn, respectively, revealing nearly similar helical 
structures for the closed and open state. In addition, the helical net 
diagrams built with the periodicity profile data of the open- and 
closed-channel  state  localize  the  bM4  non-functional  mutants  in 
the same face of the “open and closed-channel state model” (Fig. 3). 
Together, these data indicate that the bM4 TD preserves a helical 
secondary structure in the open- and closed-channel state. The fact 
that all the non-functional mutants are oriented toward the same face 
of the helix suggests a higher degree of packing within this region 
of the helix, presumably toward the interior of the protein (Fig. 3). 
Consequently, in the helical net diagrams, the last helical turn of the 
maximum oscillatory peaks diagram and the first helical turn of the 
minimum oscillatory peaks diagram do not represent an accurate 
location  of  the  non-functional  mutants. This  observation  reveals 
the limitation of the helical net diagram analysis at the extremes of 
the helix where it is very difficult to extrapolate a maximum and/or 
minimum oscillatory peak in the tryptophan-periodicity profiles.
Generally, the discrete Fourier transform (FT) analysis is used 
for converting a sequence of values into a frequency spectrum, and 
thus, it may be used to detect periodic variations in the sequences. 
Therefore,  we  coupled  FT  to TrpScanM  to  estimate  by  another 
method the mean periodicities (residues per turn) and peak ratios of 
the sequences of AChR expression (fmol/Å3) and ACh EC50 (µM) 
values (see Table 2). With these mean periodicities we were able to 
estimate  the  overall  periodicity  change  undergone  by  the  helical 
example, the αF280W mutation33 displayed an expression level of 
0.12 fmol and a functional receptor similar to WT. One possible 
explanation for the non-functional mutants found in the present 
study  is  a  deficiency  in  channel  assembly  and/or  oligomerization 
given  that  similar  expression  levels  generate  functional  and  non-
functional mutants. The remaining six mutants (L440W, F443W, 
S448W,  F452W,  S453W  and  I454W)  exhibited  similar  nAChR 
expression levels as WT.
Effect on macroscopic current response. The purpose of these 
studies is to determine the role of bM4 TD on channel function 
and to assess the role that lipid-protein interactions may have on the 
AChR function. We used the two-electrode voltage clamp technique 
and ACh concentrations ranging from 1 to 300 µM to generate 
the dose response curve for each mutation. Two mutants (L440W 
and  S453W)  enhanced  the  maximum  macroscopic  response  by 
almost 1.5–2-fold compared to WT. Ten mutants (F439W, Y441W, 
F443W,  F444W,  V445W,  I446W,  S448W,  I449W,  G450W  and 
F452W) significantly reduced the maximum macroscopic response; 
C447W, V442W and I454W displayed a similar response as WT. 
The Imax values were normalized to AChR expression levels (fmol) in 
each oocyte. The normalized macroscopic response (Imax/fmol) for six 
mutants (Y441W, V442W, F444W, C447W, I449W and S453W) 
was increased by 1.5–2-fold as compared with WT. Four mutants 
(V445W, S448W, G450W and I454W) displayed a decrease of Imax/
fmol values, whereas the mutants F439W, L440W, F443W, I446W 
and F452W were similar to WT.
All  the  mutations  that  produced  functional  AChRs  showed 
typical sigmoidal ACh dose-response curve profiles (Fig. 1B). The 
bY441W and bY449W mutants showed shallower curves with supe-
rior horizontal asymptotes >1 (I/Imax Fig. 1B). This could explain 
the absence of a clear saturation plateau. The potency to acetylcho-
line (EC50) was reduced in five mutants (F439W, L440W, V442W, 
F443W and C447W) 2–4 fold compared to WT. The reduction in 
EC50 values could be due to changes in affinity and/or efficacy of 
ACh. On the other hand, five mutants (V445W, I446W, S448W, 
S453W and I454W) exhibited potency similar to WT. EC50 values 
increased for five mutants (Y441W, F444W, I449W, G450W and 
F452W) 2–4-fold compared to WT values. Even though the mutant 
I449W displays an EC50 value of 128 µM, the dose-response curve 
does not reflect this difference due to the small ionic current and 
small expression levels of the mutant. Most of the mutants display 
ionic current traces similar to those of WT. In comparison to WT, 
only three mutants (I440W, C447W and S453W) display distinct 
peak currents (Fig. 1C). Those mutations have a peak current over 
7,000 nA larger than WT. A previous single-channel study demon-
strated  that  the  bC447W  mutation  increases  the  open  channel 
probability,41 a kinetic pattern that could be shared with the other 
two mutants (I440W and S453W). The mutant F439W displays a 
macroscopic ionic current trace with a slow decay phase compared to 
WT, but the amount of ionic current is too small (<3,500 nA) and 
a single-channel analysis might be tedious. The small ionic currents 
displayed by the mutant bI449W (<2700 nA) does not allow for 
an  accurate  estimation  of  desensitization  kinetics.  Although  a 
single-channel kinetics analysis would permit the study of the desen-
sitization kinetics of the mutant bI449W, such an analysis does not 
seems feasible due to the low amount of macroscopic ionic current 
per oocyte.Tryptophan-scanning of the acetylcholine receptor bM4 domain
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  open-channel states, respectively. From these results we could deter-
mine that the helical structure of the bM4 domain underwent an 
overall conformational change of ~0.4 residues/turn during confor-
mational transition states from closed- and open-channel states of 
the AChR. In addition, the strength of these peaks to predict helical 
secondary structures was evaluated by the peak ratio equation as the 
ratio of P(ω) in the peak range (peak - 15° ≤ peak ≤ peak + 15°) 
relative  to  P(ω)  over  the  whole  spectrum. The  peak  ratio  values 
were 1.43 and 1.37 for closed- and open-channel states, respectively, 
resulting in peak abundances of 24–25% from whole spectra, and 
secondary structure of the bM4 domain during ion-channel acti-
vation between closed- and open-channel states. Using FT, AChR 
expression and ACh EC50 values were decomposed at the FT power 
spectra into multiple peaks with different abundances, suggesting 
that  the  tryptophan-periodicity  profiles  (TrpPPs)  may  be  divided 
into several periodicities with diverse oscillation patterns (Fig. 2B 
and D). The rotation angles of the peaks in the FT power spectra 
found in the vicinity that correspond to mean periodicities of the 
TrpPPs were used to calculate the mean periodicity provided by FT 
power spectra, showing 2.18 and 2.58 residues/turn for closed- and 
Figure 1. Sequence alignments of the bM4 domain and functional response of wild-type and bM4-mutant AChRs. (A) LFLYVFFVICSIGTGTFSIF (blue font) were 
examined in the current study. ***YV*FVICSI**FS** (highlighted in yellow and position number in green) are non-conserved residues among AChR species. 
Y*(441), F(443), F(444), C*(447) and S*(448) were labeled as lipid-exposed positions using photolabeling affinity [125I]TID for the underline residues and 
[3H]DAF for the asterisks residues.13,42 The numbers at the bottom indicate the position in the Torpedo b1-subunit. (B) displays dose-response curves that were 
standardized to [125I]-α-bungarotoxin (fmol) bound to AChR expressed on the oocyte surface membrane. The insert in each curve shows the dose-response 
curves normalized to maximum current. For the sake of clarity, we split the mutants in two groups (L438W to I446W and C447W to F455W). (C) shows 
representative families of macroscopic ionic current traces evoked by 1–300 µM ACh and recorded through two-electrode voltage clamp.Tryptophan-scanning of the acetylcholine receptor bM4 domain
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(from αC412W to αV425W) gave only one non-
functional mutant (αI417W). The aforementioned 
studies clearly demonstrate that γM4 and αM4 can 
tolerate the bulky tryptophan side chain compared 
to  the  bM4. These  results  suggest  that  the  bM4 
domain is more tightly-packed than the γM4 and 
αM4 TDs. In addition, γM4 and αM4 TDs report 
a movement of approximately 3.3 and 3.6 residues 
per helical turn, respectively, compared to the bM4 
TD that reports only a movement of 2.4 residues per 
helical turn.29,33 It is noteworthy to mention that 
the beta subunit does not contribute to the structural 
domains of the agonist binding site of the AChR; 
therefore, the present data is consistent with a more 
rigid, tightly-packed domain than that of γM4 and 
αM4 TDs.
We found that 11 mutations (L438W, F439W, 
Y441W, V442W, F444W, V445W, C447W, I449W, 
G450W, T451W and F455W) produced a signif-
icant  reduction  in  the  AChR  expression  levels, 
suggesting  a  reduced  efficiency  of  assembly  and/
or  oligomerization  of  the  AChR.  Eight  (L438W, 
F439W, V442W, V445W, I449W, G450W, T451W 
and  F455W)  of  the  eleven  mutations  are  resi-
dues that could be oriented toward the interior of 
the AChR due to undetected labeling of previous 
3-trifluoromethyl-3-(m-[125I]iodophenyl)diazirine) 
photolabeling  studies  in  the  Torpedo  californica 
AChR.13 However, according to the photolabeling 
studies,  mutations  Y441W,  F444W  and  C447W 
are  presumably  oriented  toward  the  lipid  inter-
face. Both Y441W and F444W mutants also have 
a  lower  macroscopic  response  and  a  higher  EC50 
value than that found for WT, suggesting an impaired ion channel 
function of this mutant. The C447W displayed significantly lower 
expression levels than did WT and also showed a lower EC50 and a 
higher macroscopic response than did WT. These results suggest an 
enhancement in the modulation and/or ion channel properties of 
the AChR that could categorize the C447W mutant as a gain-of-
function mutation.
L440W displays an increase in the macroscopic response. L440W 
like C447W displays a reduction in the EC50 for ACh and a higher 
macroscopic current response compared to WT. Y441W, F444W, 
I449W, G450W and F452W displayed a lower macroscopic response, 
suggesting an impaired ion channel function. These mutants also 
displayed higher EC50 values. The other mutants displayed expres-
sion and macroscopic levels lower or similar to those of WT.
Mutations that produced a gain-of-function response (i.e., L440W, 
V442W, C447W and S423W) are clustered at opposite sides of the 
helix. Positions C447 and L440 are facing the lipid protein interface 
(Fig. 4A and B); thus, the observed gain-of-function of these mutants 
is  consistent  with  those  of  previously  reported  positions  such  as 
those of the αC418W. In contrast, positions V442 and S453 are 
facing the interior of the protein (Fig. 4B and C). According to the 
nAChR structure, both positions are oriented to a crevice facing the 
M1 domain (Fig. 4C). The size of the crevice allows for the accom-
modation of a bulky side chain and this could explain the significant 
thus  predicting  reliable  helical  secondary  structures  for  the  bM4 
domain. Taken together, FT-TrpScanM data suggest that the helical 
structure of the bM4 domain undergoes a conformational change of 
0.4 residues/turn during channel activation of the AChR, and vali-
date the results of periodicity change from TrpPPs data.
Discussion
The highly hydrophobic M4 TD of the nAChR is the least evolu-
tionarily conserved of the four domains composing the AChR (Fig. 
1A). Previous studies demonstrate that all the membrane spanning 
domains  M1,  M2,  M3  and  M4  adopt  an  α-helical  conforma-
tion.12,13,17,19,42 In the present study, we used TrpScanM to examine 
the functional and structural role of 18 residues (from L438 to F455) 
of the bM4 TD in AChR.
Functional  Interpretation  vs.  spatial  orientation.  Tryptophan 
substitution at position L438W, T551W and F455W resulted in 
non-functional AChRs (Table 1). These mutants displayed very low 
AChR expression levels and no detectable ionic currents. Previous 
photoaffinity  labeling  studies  have  suggested  that  these  residues 
are located at the interior of the protein.13,42 These results contrast 
with a previous study of the lipid-exposed γM4,32 and αM4,29 TD 
in  which  all  the  γM4  tryptophan  replacements  (from  γC451W 
to  γG462W),  including  residues  located  at  the  interior  of  the 
domain, gave functional AChRs, and αM4 tryptophan replacements 
Figure 2. Periodicity profiles and Fourier transform of ACh EC50 and AChR-normalized expres-
sion of the Torpedo tryptophan substitutions along the bM4 transmembrane domain. (A and C) 
show the periodicity profiles of the open-channel state (ACh EC50 value) and closed-channel 
state (AChR-normalized expression), respectively. The values inside the boxes indicate the 
number of residues per helical turn between the adjacent maximums and minimums peaks. (B 
and D) represent the Fourier transform power spectrums from entire sequences of the AChR 
expression (fmol/Å3) (closed-channel state) and ACh EC50 (µM) (open-channel state) values 
that come from the tryptophan-scanning periodicity profiles data (A and C). Grey areas within 
the curves indicate the corresponding peak to average oscillation of the tryptophan-periodicity 
profiles in the closed- (D) and open-channel states (B).Tryptophan-scanning of the acetylcholine receptor bM4 domain
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One  interesting  observation  is  that  the  ACh-binding  sites 
lie  at  the  α-γ  and  α-δ  subunit  interface,  giving  the  b-subunit 
a  more  supporting  role  during  channel  activation.  Another 
characteristic of the b-subunit is that, in contrast to the other 
subunit, the bM4 domain revealed very small subunit movement 
between  channel  activation.14,47  Taking  into  consideration  the 
structural characteristics of the bM4 TD, one type of movement 
that could occur during channel activation is the one proposed 
in  the  global  movement  theory.  Previous  experiments  on  the 
structural  mechanisms  of  gating  used  electron  microscopy  on 
Torpedo  postsynaptic  membranes48,49  and  rapid  spray-freezing 
techniques to trip the AChR in the open-channel form.14 Those 
experiments showed that binding of ACh initiates two intercon-
nected  events  in  the  ligand-binding  domain.14  One  is  a  local 
disturbance in the region of ACh-binding sites, and the other is 
a  larger-scale  conformational  change  that  propagates  along  the 
transmembrane  domains.14  In  some,  the  rate-equilibrium  free 
energy relationship analysis of some domains in the AChR suggest 
that the closed- vs. open-gating conformational change occurs as 
expression  of  these  mutants. The  observed  gain-of-
functions of the V442W and S453W mutations could 
be due to interactions of these positions with the M1 
domain during channel gating. One possibility is that 
the  hydrophobic  interactions  with  the  M1,  which 
contribute to the open pore structure, could delay the 
closing of the channel.
The novel αC418W mutation located in the M4 
domain  has  been  shown  to  produce  an  increase  in 
macroscopic  response,  a  lower  EC50,  and  a  lower 
expression level, all of which are similar to the charac-
teristics of bC447W.38,41,43 The functional expression 
of this novel αC418W mutation was shown to be a 
cholesterol-sensitive mutation.44 Single-channel elec-
trophysiology of αC418W showed an increase in the 
channel  open  probability,  due  to  a  decrease  in  the 
apparent channel closing rate and a probable increase 
in  the  effective  opening  rate,  again  similar  to  the 
response of bC447W.41 αC418W and bC447W share 
an additional characteristic: as a consequence of the 
mutation, this lipid-exposed mutant favors the intro-
duction of a caveolin-binding motif (CBM). Caveolae 
are  specialized  lipid  rafts  rich  in  cholesterol,  sphin-
golipids  and  caveolins.  A  consensus  CBM  sequence 
has  been  established  with  the  following  sequences: 
ΦXΦXXXXΦ  and  ΦXXXXΦXXΦ:  in  which  Φ  is 
an aromatic residue (W, F or Y) and X is any amino 
acid.45  In  the  αC418W  mutant  we  identified  a 
sequence (WIIGTVSVFA, residues 418–426) with a 
putative CBM, which is formed when cysteine in posi-
tion 418 is replaced by tryptophan. In the bC447W 
we also identified a similar sequence (FVIWSIGTF, 
residues 444–452) when cysteine in position 447 is 
replaced  by  tryptophan.  The  formation  of  putative 
CBM  by  the  incorporation  of  tryptophan  at  lipid 
exposed domains may lower the amount of receptors 
available  in  the  membrane  and  thus  could  account 
for the reduced expression levels previously reported 
for  αC418W  and  now  for  bC447W. The  αC418W  is  the  first 
lipid-exposed mutation that has been shown to produce congenital 
myasthenic syndrome in humans.46
Closed- versus open-channel states. In the present study, the 
tryptophan periodicity profiles of the bM4 TD displayed a small 
structural  difference  between  the  open-  and  closed-channel  state 
(Fig.  2A  and  C).  The  overall  helix  movement  during  channel 
activation estimated for the bM4 predicts a value of 0.4 residues-
per-turn; therefore, this domain displays reduced movement when 
compared to the αM3 TD for which a 1.0 residue-per-turn was 
recently reported33 (Fig. 2B and D). The small difference between 
the two states could be the result of one of two types of movement 
during channel activation: (i) a global subtle movement of the entire 
bM4 TD or (ii) a discrete and localized movement, both during 
channel activation (Figs. 2 and 3). The localized movement could 
occur between residues bCys447 and bThr451. This small region 
contains polar residues that are characterized as forming very stable 
and strong hydrogen bonds that could stabilize the helix during 
channel activation.
Figure 3. Localization of the bM4-mutants AChR in the open and closed-channel state. (A–D) 
exhibit the helical net diagram of the amount of amino acid per helical turn between the 
adjacent maximum and minimum oscillatory peaks of the periodicity profile of the Torpedo 
AChR bM4 domain in the open-channel state (A and B) and the closed-channel state (C and 
D). The red dots represent the loss of function residues.Tryptophan-scanning of the acetylcholine receptor bM4 domain
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Table 2    Secondary structure parameters of bM4 domain determined by tryptophan-periodicity profiles and Fourier 
transform power spectraa
Conformational states of the AChR                  Tryptophan-periodicity profiles   Fourier transform power spectra 
  Periodicity  Expected rotation angle  Rotation angle  Expected mean periodicity  Peak ratio 
  residues/turn  degree  degree  residues/turn
Closed-channel  2.14 ± 0.39  168.22  165.39  2.18  1.4255
Open-channel  2.43 ± 0.71  148.15  139.4  2.58  1.3652
aThe given values correspond to analysis performed on the entire sequences of the AChR expression and ACh EC50 values. The periodicities of the tryptophan-periodicity profiles were given as mean ± SD. The expected 
rotation angles of the tryptophan-periodicity profiles and the expected mean periodicities of the peak that corresponds to mean oscillations of the tryptophan-periodicity profiles were calculated using periodicity (residues/
turn) = 360°/rotation angle.
Figure 4. Spatial orientation of the AChR bM4 transmembrane domain. (A) display the bM4 domain along the helix. (B) shows the top view of the bM4 
domain. (C) Illustrate the b M1–M4 domains. The amino acids in cyan color represent the gain in function positions. Asterisks (*) indicates the lipid-exposed 
positions using photolabeling affinity [125I]TID (Y441, F443, I444, C447) and [3H]DAF (Y441, C447, S448). The 3D model representation is from the 
Unwin AChR 4Å14 resolution structure interpretation using Pymol viewer (PDB code 2GB9).
a Brownian conformational “wave,” with groups of residues in the 
extracellular domain moving in advance to those in the membrane 
domain.47,50,51
The present study demonstrates that the bM4 domain plays a 
more structural role during AChR channel activation. The fact that 
bM4  displays  a  larger  number  of  non-functional  mutants  and  a 
lower change in the periodicity value as compared to αM4 and γM4 
suggests a more “tightly-packed” and rigid-body domain compared 
to other transmembrane domains.
Experimental Procedures
General  experimental  procedures.  Xenopus  laevis  oocytes  were 
microinjected with the T. californica AChR complementary RNAs. 
Mutations  were  engineered  with  the  QuikChange®  site-directed 
mutagenesis  kit  (Stratagene)  and  were  confirmed  by  automated 
DNA sequencing. All mutagenic primers were designed with the 
tryptophan codon (TGG) instead of the WT codon at the desired 
position. Muscle-type AChR cRNA transcripts were synthesized with Tryptophan-scanning of the acetylcholine receptor bM4 domain
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(2)
where XMutant is the expression of the bM4-mutant AChRs; VTrp 
and VWT are the volumes of the tryptophan and original residues, 
respectively. Amino acid volume values (VTrp and VWT) are from 
crystallographic studies.52 Periodicity profiles were plotted with ACh 
EC50 or AChR expression as a function of their tryptophan substitu-
tion position along the bM4 domain. Periodicity curves were created 
through the cubic spline method with 10,000 segments using the 
GraphPad Prism 4 program. The number of residues per helical turn 
of the periodicity profiles was estimated as the amount of amino 
acids between the adjacent maximum and minimum peaks.
Fourier transform. The periodicities of AChR expression (fmol/
Å3) and ACh EC50 (µM) periodicity profiles were also determined 
by Fourier transform power spectra. The Fourier transform power 
spectra from data of AChR expression and ACh EC50 periodicity 
profiles  were  generated  using  a  least-squares  Fourier  transform 
  equation.26,27,36,53-58
       
              (3)
where P(ω) is the Fourier transform power spectrum as a function 
of angular frequency ω (rotation angle between residue around a 
helical axis), Vj is the value of AChR expression or ACh EC50 at a 
given position j, <Vj> is the mean value of Vj in the sliding window, 
and N is the number of values in the sliding window. For example, 
the Fourier transform analysis to a sequence of values from an ideal 
α-helical pattern (3.6 residues per turn) should give in the Fourier 
transform power spectrum a prominent peak at ~100°, given that the 
ω parameter is related to the number of residues per turn (n) by the 
expression ω (degree) = 360°/n.
The mean periodicities of the sequences of AChR expression and 
ACh EC50 values were estimated from the peak in the Fourier trans-
form power spectrum localized in the vicinity of the rotation angle 
as indicated by the mean periodicities of their tryptophan-periodicity 
profiles. These rotation angles from mean periodicities of the trypto-
phan-periodicity profiles were calculated using equation 5.
The relative abundance of the peak that corresponds to mean 
oscillations of the tryptophan-periodicity profiles was calculated by 
the peak ratio equation using MATLAB® 7.4 program:
 
              (4)
where Peak is the degrees of rotation angle (ω) of the peak that corre-
sponds  to  mean  oscillations  of  the  tryptophan-periodicity  profiles 
and P(ω) is the Fourier transform power spectrum. A Peak ratio >2, 
which occupies at least 33% of the whole power spectrum, has been 
the mMESSAGE mMACHINE® kit (Ambion). Oocytes were incu-
bated for 3 days with fresh liquid medium at 19°C.
Voltage clamp. Macroscopic ACh-induced currents were recorded 
with a whole-cell two-electrode voltage clamp configuration using the 
Gene Clamp 500B amplifier (Axon Instruments) at room tempera-
ture.  Electrodes  were  filled  with  3  M  KCl,  resistances  <2  MΩ. 
Impaled oocytes were automatically perfused with MOR-2 buffer 
[82.5 mM NaCl, 2.5 mM KCl, 5 mM MgCl2, 1 mM Na2HPO4, 
0.2 mM CaCl2, 5 mM HEPES and 0.5 mM EGTA (pH 7.4)] at a 
rate of 0.43 mL/s using a Perfusion Valve Controller VC-8 (Warner 
Instruments). Membrane potential was held at -70 mV. Membrane 
currents were filtered at 100 Hz and digitized at 1 kHz using a 
DigiData 1322A interface (Axon Instruments). Data acquisition was 
conducted through the Clampex 9.2 program (Axon Instruments). 
Dose-response curves were generated from macroscopic peak currents 
(I) obtained from six different ACh concentrations (1, 3, 10, 30, 
100 and 300 µM ACh). Dose-response curves were fitted through 
the sigmoidal dose-response equation with variable slope using the 
GraphPad Prism 4 program (GraphPad):
        
(1)
where  I  is  the  macroscopic  peak  ionic  current  at  a  given  ACh 
concentration; Imin and Imax are the smallest and the largest currents 
observed,  respectively;  EC50  is  the  concentration  of  acetylcholine 
that provokes a response halfway between Imin and Imax; and the Hill 
Slope is the steepness of the dose-response curve.
[125I]-α-bungarotoxin  binding  assays.  [125I]-α-bungarotoxin 
([125I]-α-BgTx)  (PerkinElmer)  binding  assays  were  performed 
immediately after the voltage clamp measurement on the same intact 
oocytes. Oocytes were incubated in 20 nM [125I]-α-BgTx, 5 mg/mL 
BSA, MOR-2 without EGTA and in the absence of agonist at room 
temperature for 2 hours. Non-injected oocytes were incubated under 
the same conditions to measure non-specific binding. The excess of 
toxin was removed by washing each oocyte with 25 mL of MOR-2 
without EGTA. Calibration curves were plotted with radioactivity 
(counts per minute) as a function of concentration [125I]-α-BgTx 
(fmol). Calibration curves were used to determine AChR expression 
levels in each oocyte. Radioactivity was measured using a Beckman 
5500 gamma counter (Beckman Coulter).
Normalized  macroscopic  AChR  response.  The  normalized 
response (nA/fmol) of each oocyte was assessed as the ratio of the 
macroscopic peak current (nA) generated at 300 µM ACh to the 
superficial [125I]-α-BgTx binding (fmol).
Statistical analysis. Each bM4-mutant was compared with the 
WT for each parameter using a one-way ANOVA with Dunnett’s 
post test performed in the GraphPad Prism 4 program (see Table 
1). The mean of the amount of residues per turn of the closed- and 
open-channel states were compared using an unpaired Student’s t-test 
with Welch’s correction through the GraphPad Prism 4 program.
Periodicity  profiles.  The  number  of  residues  per  helical  turn 
for the closed- and open-channel states was determined by AChR 
expression  and  ACh  EC50  periodicity  profiles,  respectively.  The 
AChR expression of each mutant was standardized to the change 
in amino acid volume (Å3) caused by each tryptophan substitution 
(fmol/Å3). Standardized expression (XStandardized) was calculated as:Tryptophan-scanning of the acetylcholine receptor bM4 domain
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and provide evidence to support that the α-BgTx-binding assay is a 
reliable method to measure assembled-nAChR levels in the   plasmatic 
membrane.19 Thus, it is very unlikely that α-BgTx binding affinity 
is  altered  in  response  to  these  mutations  made  within  bTM4. 
Accordingly, the pattern of normalized response seems to depend on 
the mutant itself, rather than on variation in expression levels.
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where n is the number of residues per helical turn. Helical rise per 
residue (d) for each helical turn was determined using:
        
(6)
where Δ is the amount of amino acids between the positions of the 
residue and anterior peak, b is the magnitude of the maximum rise in 
the anterior helical turn (thus the rise at 360°), p is the helical pitch 
per helical turn estimated through p (Å) = -1 x n + 9, and n is the 
amount of residues per helical turn.
Molecular modeling. The structural models of the closed- and 
open-channel states were built with the periodicity profile data using 
the Deep Viewer/Swiss-PdbViewer 3.7 program (http://www.expasy.
org/spdbv/). The backbone of each helical structure was adjusted to 
the number of residues per helical turn determined by periodicity 
profiles using:
        
(7)
where Ω is the angle per residue and ϕ and Ψ are backbone dihedral 
angles. The helical structures were energetically minimized. The back-
bones of the helical structures were superimposed to compare their 
structure. The quality of the superimposition between two helical 
structures was evaluated by calculating the root mean squared devia-
tion. The mobility of the backbone atoms between helical structures 
was displayed using B-factor in the superposed models. The length 
(h), helical pitch (p), and helical rise per amino acid (d) of the helical 
structure  were  calculated  with  the  Deep Viewer/Swiss-PdbViewer 
3.7 program. The radius (r) of the helical structure was estimated 
using r2 = (p/2)2 + d2, considering the helical structure as a cylinder. 
The volume (V) of the helical structure was assessed using V = πr2h. 
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